Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cytoskeletal protein binding	CACNA1D SETD2 BRCA1 BRCA2 MYO5A CFL1 CEP70 KIF14 PSTPIP2 NEB MAP3K1 MYO5C	7.36e-05	1099	59	12	GO:0008092
GeneOntologyBiologicalProcess	cytokinesis	USP8 SETD2 BRCA2 CFL1 KIF14 EXOC1	1.87e-05	204	56	6	GO:0000910
GeneOntologyBiologicalProcess	chromatin organization	RAG1 RIF1 SETD2 PBRM1 BRCA1 LMNA BRCA2 BAZ2B SYCP1 PHF14 ZNF445	2.42e-05	896	56	11	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	RAG1 RIF1 SETD2 PBRM1 BRCA1 LMNA BRCA2 BAZ2B SYCP1 PHF14 ZNF445	6.53e-05	999	56	11	GO:0071824
GeneOntologyCellularComponent	lateral element	BRCA1 BRCA2 SYCP1	1.81e-05	19	57	3	GO:0000800
GeneOntologyCellularComponent	neuron spine	USP8 ADRB2 ABR CFL1 EEA1 EPHA4	5.61e-05	247	57	6	GO:0044309
GeneOntologyCellularComponent	Schaffer collateral - CA1 synapse	ADRB2 ABR MYO5A EEA1 EPHA4	6.45e-05	155	57	5	GO:0098685
GeneOntologyCellularComponent	synaptonemal complex	BRCA1 BRCA2 SYCP1	2.68e-04	46	57	3	GO:0000795
GeneOntologyCellularComponent	synaptonemal structure	BRCA1 BRCA2 SYCP1	2.68e-04	46	57	3	GO:0099086
GeneOntologyCellularComponent	dendritic spine	USP8 ADRB2 ABR CFL1 EPHA4	5.12e-04	242	57	5	GO:0043197
GeneOntologyCellularComponent	chromosome, telomeric repeat region	RIF1 ACD	6.51e-04	14	57	2	GO:0140445
GeneOntologyCellularComponent	condensed chromosome	RIF1 PBRM1 BRCA1 BRCA2 SYCP1	1.48e-03	307	57	5	GO:0000793
GeneOntologyCellularComponent	DNA repair complex	BRCA1 BRCA2	1.78e-03	23	57	2	GO:1990391
GeneOntologyCellularComponent	early endosome	PI4K2B USP8 ADRB2 MYO5A EEA1 EPHA4	1.93e-03	481	57	6	GO:0005769
GeneOntologyCellularComponent	condensed nuclear chromosome	BRCA1 BRCA2 SYCP1	1.97e-03	91	57	3	GO:0000794
HumanPheno	Acholic stools	BRCA1 BRCA2 ROS1	4.99e-06	9	21	3	HP:0011985
HumanPheno	Biliary tract neoplasm	BRCA1 BRCA2 ROS1	3.27e-05	16	21	3	HP:0100574
MousePheno	abnormal skin pigmentation	RAG1 BRCA1 LMNA ACD MYO5A	7.46e-06	87	44	5	MP:0002095
MousePheno	abnormal epidermal melanocyte morphology	LMNA MYO5A	5.79e-05	4	44	2	MP:0009388
MousePheno	abnormal double-strand DNA break repair	RIF1 BRCA1 LMNA BRCA2	6.73e-05	70	44	4	MP:0010948
MousePheno	hairpin sperm flagellum	TTC29 ROS1 CEP128	1.00e-04	29	44	3	MP:0009243
Domain	Znf_C2H2-like	RAG1 ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 EEA1 ZNF782 ZNF445	2.86e-05	796	58	11	IPR015880
Domain	ZnF_C2H2	RAG1 ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 EEA1 ZNF782 ZNF445	3.28e-05	808	58	11	SM00355
Domain	-	RAG1 RC3H2 BRCA1 BAZ2B PHF14 EEA1 OBI1 MAP3K1	7.00e-05	449	58	8	3.30.40.10
Domain	Znf_RING/FYVE/PHD	RAG1 RC3H2 BRCA1 BAZ2B PHF14 EEA1 OBI1 MAP3K1	8.17e-05	459	58	8	IPR013083
Domain	Myosin_S1_N	MYO5A MYO5C	9.42e-05	5	58	2	IPR008989
Domain	ZINC_FINGER_C2H2_2	ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 EEA1 ZNF782 ZNF445	1.22e-04	775	58	10	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 EEA1 ZNF782 ZNF445	1.25e-04	777	58	10	PS00028
Domain	DIL	MYO5A MYO5C	1.41e-04	6	58	2	PF01843
Domain	Dilute_dom	MYO5A MYO5C	1.41e-04	6	58	2	IPR002710
Domain	DILUTE	MYO5A MYO5C	1.41e-04	6	58	2	PS51126
Domain	DIL	MYO5A MYO5C	1.41e-04	6	58	2	SM01132
Domain	Znf_C2H2	ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 EEA1 ZNF782 ZNF445	1.67e-04	805	58	10	IPR007087
Domain	-	RAG1 ZNF594 ZFHX4 ZNF184 ZNF790 ZBTB21 ZFHX3 ZNF782 ZNF445	2.27e-04	679	58	9	3.30.160.60
Domain	zf-C2H2	ZNF594 ZFHX4 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 ZNF782 ZNF445	2.65e-04	693	58	9	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	RAG1 ZNF594 ZFHX4 ZNF184 ZNF790 ZBTB21 ZFHX3 ZNF782 ZNF445	2.67e-04	694	58	9	IPR013087
Domain	IQ	MYO5A SCN7A MYO5C	2.04e-03	81	58	3	SM00015
Domain	ZF_RING_1	RAG1 RC3H2 BRCA1 OBI1 MAP3K1	2.07e-03	291	58	5	PS00518
Domain	ZF_RING_2	RAG1 RC3H2 BRCA1 OBI1 MAP3K1	2.30e-03	298	58	5	PS50089
Domain	RING	RAG1 RC3H2 BRCA1 OBI1 MAP3K1	2.54e-03	305	58	5	SM00184
Domain	IQ_motif_EF-hand-BS	MYO5A SCN7A MYO5C	2.76e-03	90	58	3	IPR000048
Domain	Bromodomain_CS	PBRM1 BAZ2B	2.94e-03	26	58	2	IPR018359
Domain	Znf_RING	RAG1 RC3H2 BRCA1 OBI1 MAP3K1	3.38e-03	326	58	5	IPR001841
Domain	ZnF_U1	ZFHX4 ZFHX3	3.65e-03	29	58	2	SM00451
Domain	Znf_U1	ZFHX4 ZFHX3	3.65e-03	29	58	2	IPR003604
Domain	Ion_trans_dom	CACNA1D SCN7A ITPR2	5.35e-03	114	58	3	IPR005821
Domain	Ion_trans	CACNA1D SCN7A ITPR2	5.35e-03	114	58	3	PF00520
Domain	BROMODOMAIN_1	PBRM1 BAZ2B	5.89e-03	37	58	2	PS00633
Domain	Myosin_head_motor_dom	MYO5A MYO5C	6.20e-03	38	58	2	IPR001609
Domain	Bromodomain	PBRM1 BAZ2B	6.20e-03	38	58	2	PF00439
Domain	MYOSIN_MOTOR	MYO5A MYO5C	6.20e-03	38	58	2	PS51456
Domain	Myosin_head	MYO5A MYO5C	6.20e-03	38	58	2	PF00063
Domain	MYSc	MYO5A MYO5C	6.20e-03	38	58	2	SM00242
Domain	-	RC3H2 ZC3H6	6.85e-03	40	58	2	4.10.1000.10
Domain	BROMODOMAIN_2	PBRM1 BAZ2B	7.19e-03	41	58	2	PS50014
Domain	BROMO	PBRM1 BAZ2B	7.54e-03	42	58	2	SM00297
Domain	Bromodomain	PBRM1 BAZ2B	7.54e-03	42	58	2	IPR001487
Domain	-	PBRM1 BAZ2B	7.54e-03	42	58	2	1.20.920.10
Pathway	REACTOME_MEIOSIS	BRCA1 LMNA ACD BRCA2 SYCP1	2.41e-05	120	41	5	M529
Pathway	REACTOME_MEIOTIC_SYNAPSIS	BRCA1 LMNA ACD SYCP1	7.52e-05	78	41	4	M1061
Pathway	REACTOME_REPRODUCTION	BRCA1 LMNA ACD BRCA2 SYCP1	8.98e-05	158	41	5	M26956
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	USP8 PDE6A BRCA1 LMNA MYO5A CFL1 ZBTB21 SYCP1 PHF14 EEA1 NEB KRT79 CEP128 OBI1 HSPA6 GOLGB1 ESF1 EPHA4	2.08e-11	1442	60	18	35575683
Pubmed	Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects.	BRCA1 BRCA2 MAP3K1	4.88e-09	3	60	3	20809358
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	ZFHX4 BRCA2 ZBTB21 KIF14 ZFHX3 ICE1 OBI1 HSPA6 GOLGB1	4.13e-08	418	60	9	34709266
Pubmed	Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2 MAP3K1	4.87e-08	5	60	3	18355772
Pubmed	Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer.	RIF1 BRCA1 BRCA2	4.87e-08	5	60	3	38244928
Pubmed	Breast cancer susceptibility variants alter risks in familial disease.	BRCA1 BRCA2 MAP3K1	9.73e-08	6	60	3	19617217
Pubmed	Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.	SETD2 PBRM1 BRCA1 BRCA2 MAP3K1	1.54e-07	71	60	5	28319113
Pubmed	Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.	BRCA1 BRCA2 MAP3K1	5.81e-07	10	60	3	37592023
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RIF1 SETD2 BRCA1 LMNA BRCA2 BAZ2B CFL1 ZNF451 PHF14 ICE1 ESF1	6.27e-07	954	60	11	36373674
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	RIF1 PBRM1 LMNA MYO5A CFL1 ZBTB21 KIF14 EEA1 GOLGB1 MYO5C ITPR2	1.25e-06	1024	60	11	24711643
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	BRCA1 BRCA2 BAZ2B ZNF451 ZBTB21 ESF1	2.37e-06	222	60	6	37071664
Pubmed	Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.	BRCA1 BRCA2	2.93e-06	2	60	2	29480828
Pubmed	A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.	BRCA1 BRCA2	2.93e-06	2	60	2	17924331
Pubmed	Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.	BRCA1 BRCA2	2.93e-06	2	60	2	12833555
Pubmed	Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.	BRCA1 BRCA2	2.93e-06	2	60	2	14735173
Pubmed	Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	16032702
Pubmed	Oral contraceptive use and BRCA penetrance: a case-only study.	BRCA1 BRCA2	2.93e-06	2	60	2	19549808
Pubmed	Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.	BRCA1 BRCA2	2.93e-06	2	60	2	34101484
Pubmed	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.	BRCA1 BRCA2	2.93e-06	2	60	2	26961146
Pubmed	Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.	BRCA1 BRCA2	2.93e-06	2	60	2	20512419
Pubmed	Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.	BRCA1 BRCA2	2.93e-06	2	60	2	37804357
Pubmed	Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.	BRCA1 BRCA2	2.93e-06	2	60	2	22053997
Pubmed	BRCA mutations in women with inflammatory breast cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	29044548
Pubmed	Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.	BRCA1 BRCA2	2.93e-06	2	60	2	33834176
Pubmed	Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.	BRCA1 BRCA2	2.93e-06	2	60	2	18200524
Pubmed	Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.	BRCA1 BRCA2	2.93e-06	2	60	2	29298688
Pubmed	Fertility in women with BRCA mutations: a case-control study.	BRCA1 BRCA2	2.93e-06	2	60	2	19200971
Pubmed	Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.	BRCA1 BRCA2	2.93e-06	2	60	2	16030099
Pubmed	Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.	BRCA1 BRCA2	2.93e-06	2	60	2	28212807
Pubmed	Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	11448436
Pubmed	Rapid evolution of BRCA1 and BRCA2 in humans and other primates.	BRCA1 BRCA2	2.93e-06	2	60	2	25011685
Pubmed	Breast magnetic resonance imaging for screening high-risk women.	BRCA1 BRCA2	2.93e-06	2	60	2	23928241
Pubmed	Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	35980168
Pubmed	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.	BRCA1 BRCA2	2.93e-06	2	60	2	11377596
Pubmed	BRCA mutations and risk of prostate cancer in Ashkenazi Jews.	BRCA1 BRCA2	2.93e-06	2	60	2	15131025
Pubmed	Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.	BRCA1 BRCA2	2.93e-06	2	60	2	20033483
Pubmed	Health survey and assessment of the polymorphisms BRCA1/P871L, BRCA1/Q356R, and BRCA2/N372H in female gas station workers in Rio de Janeiro.	BRCA1 BRCA2	2.93e-06	2	60	2	28862356
Pubmed	BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.	BRCA1 BRCA2	2.93e-06	2	60	2	22425665
Pubmed	BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.	BRCA1 BRCA2	2.93e-06	2	60	2	18752448
Pubmed	Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.	BRCA1 BRCA2	2.93e-06	2	60	2	22425664
Pubmed	Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.	BRCA1 BRCA2	2.93e-06	2	60	2	22970155
Pubmed	Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.	BRCA1 BRCA2	2.93e-06	2	60	2	34304065
Pubmed	Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.	BRCA1 BRCA2	2.93e-06	2	60	2	26625823
Pubmed	Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	26852015
Pubmed	Meta-analysis of BRCA1 and BRCA2 penetrance.	BRCA1 BRCA2	2.93e-06	2	60	2	17416853
Pubmed	Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.	BRCA1 BRCA2	2.93e-06	2	60	2	18175183
Pubmed	Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.	BRCA1 BRCA2	2.93e-06	2	60	2	38057686
Pubmed	Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.	BRCA1 BRCA2	2.93e-06	2	60	2	27914478
Pubmed	BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.	BRCA1 BRCA2	2.93e-06	2	60	2	16455195
Pubmed	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	BRCA1 BRCA2	2.93e-06	2	60	2	23810788
Pubmed	Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.	BRCA1 BRCA2	2.93e-06	2	60	2	29727326
Pubmed	Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.	BRCA1 BRCA2	2.93e-06	2	60	2	35871032
Pubmed	Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.	BRCA1 BRCA2	2.93e-06	2	60	2	22739995
Pubmed	The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.	BRCA1 BRCA2	2.93e-06	2	60	2	27794048
Pubmed	Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.	BRCA1 BRCA2	2.93e-06	2	60	2	20972632
Pubmed	BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.	BRCA1 BRCA2	2.93e-06	2	60	2	19499246
Pubmed	Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.	BRCA1 BRCA2	2.93e-06	2	60	2	19656164
Pubmed	Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	15986445
Pubmed	Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	18165636
Pubmed	Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.	BRCA1 BRCA2	2.93e-06	2	60	2	23615136
Pubmed	Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.	BRCA1 BRCA2	2.93e-06	2	60	2	29982601
Pubmed	Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	28343309
Pubmed	BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.	BRCA1 BRCA2	2.93e-06	2	60	2	17925560
Pubmed	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	27601588
Pubmed	Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	23918944
Pubmed	Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.	BRCA1 BRCA2	2.93e-06	2	60	2	33558422
Pubmed	Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.	BRCA1 BRCA2	2.93e-06	2	60	2	30430339
Pubmed	Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.	BRCA1 BRCA2	2.93e-06	2	60	2	33534430
Pubmed	BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?	BRCA1 BRCA2	2.93e-06	2	60	2	34137566
Pubmed	BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.	BRCA1 BRCA2	2.93e-06	2	60	2	33918338
Pubmed	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	26181175
Pubmed	Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.	BRCA1 BRCA2	2.93e-06	2	60	2	14517958
Pubmed	Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.	BRCA1 BRCA2	2.93e-06	2	60	2	18559571
Pubmed	BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.	BRCA1 BRCA2	2.93e-06	2	60	2	27225819
Pubmed	BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.	BRCA1 BRCA2	2.93e-06	2	60	2	18559594
Pubmed	Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.	BRCA1 BRCA2	2.93e-06	2	60	2	31131559
Pubmed	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	BRCA1 BRCA2	2.93e-06	2	60	2	11981002
Pubmed	Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.	BRCA1 BRCA2	2.93e-06	2	60	2	29020660
Pubmed	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	BRCA1 BRCA2	2.93e-06	2	60	2	21934105
Pubmed	Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.	BRCA1 BRCA2	2.93e-06	2	60	2	28199346
Pubmed	Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.	BRCA1 BRCA2	2.93e-06	2	60	2	18092194
Pubmed	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.	BRCA1 BRCA2	2.93e-06	2	60	2	16541324
Pubmed	Investigating the relationship between BRCA1 and BRCA2 genes methylation profile and sperm DNA fragmentation in infertile men.	BRCA1 BRCA2	2.93e-06	2	60	2	31095775
Pubmed	Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.	BRCA1 BRCA2	2.93e-06	2	60	2	36385461
Pubmed	Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?	BRCA1 BRCA2	2.93e-06	2	60	2	26254840
Pubmed	Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.	BRCA1 BRCA2	2.93e-06	2	60	2	19491894
Pubmed	Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	29116468
Pubmed	BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.	BRCA1 BRCA2	2.93e-06	2	60	2	26026974
Pubmed	Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.	BRCA1 BRCA2	2.93e-06	2	60	2	24306927
Pubmed	[Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].	BRCA1 BRCA2	2.93e-06	2	60	2	15059511
Pubmed	The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.	BRCA1 BRCA2	2.93e-06	2	60	2	27880720
Pubmed	BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.	BRCA1 BRCA2	2.93e-06	2	60	2	12112655
Pubmed	Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?	BRCA1 BRCA2	2.93e-06	2	60	2	22339411
Pubmed	Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.	BRCA1 BRCA2	2.93e-06	2	60	2	34906479
Pubmed	Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).	BRCA1 BRCA2	2.93e-06	2	60	2	29740170
Pubmed	Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers.	BRCA1 BRCA2	2.93e-06	2	60	2	20043088
Pubmed	Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.	BRCA1 BRCA2	2.93e-06	2	60	2	12376518
Pubmed	Characterization and in silico analyses of the BRCA1/2 variants identified in individuals with personal and/or family history of BRCA-related cancers.	BRCA1 BRCA2	2.93e-06	2	60	2	32599251
Pubmed	Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.	BRCA1 BRCA2	2.93e-06	2	60	2	20537530
Pubmed	Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.	BRCA1 BRCA2	2.93e-06	2	60	2	11039575
Interaction	PHF21A interactions	ZFHX4 BRCA2 KIF14 ZFHX3 EXOC1 ICE1 OBI1 HSPA6 GOLGB1	7.43e-07	343	60	9	int:PHF21A
Interaction	NUP43 interactions	RIF1 SETD2 PBRM1 BRCA1 LMNA BRCA2 BAZ2B ZFHX3 ICE1 HSPA6 ELP4	2.01e-06	625	60	11	int:NUP43
Interaction	MAGEA9 interactions	PI4K2B RC3H2 ZFHX4 BRCA2 CEP95 KIF14 ITPR2	2.74e-06	208	60	7	int:MAGEA9
Interaction	KDM1A interactions	BRCA1 ZFHX4 BRCA2 ZNF451 ZBTB21 CEP70 KIF14 ZFHX3 EXOC1 ICE1 OBI1 HSPA6 GOLGB1	3.10e-06	941	60	13	int:KDM1A
Interaction	MDC1 interactions	RAG1 RIF1 SETD2 BRCA1 LMNA ACD BRCA2 KIF14 ICE1	3.50e-06	414	60	9	int:MDC1
Interaction	NINL interactions	BRCA1 LMNA BRCA2 MYO5A CEP95 CFL1 KIF14 ZFHX3 CEP128	7.91e-06	458	60	9	int:NINL
Interaction	CEP135 interactions	BRCA2 CEP95 CEP70 KIF14 CEP128 GOLGB1 ESF1	1.58e-05	272	60	7	int:CEP135
Interaction	SNRNP40 interactions	RC3H2 SETD2 BRCA1 LMNA BRCA2 BAZ2B ZNF451 RAVER2 ZBTB21 ZFHX3	1.68e-05	637	60	10	int:SNRNP40
Interaction	CSNK2A3 interactions	ANKRD36B ABR KIF14 ANKRD36 ANKRD36C	1.90e-05	110	60	5	int:CSNK2A3
Interaction	FLNA interactions	RC3H2 ADRB2 BRCA1 LMNA BRCA2 MYO5A CFL1 KIF14 HSPA6 MYO5C	1.95e-05	648	60	10	int:FLNA
Interaction	GAPDH interactions	RIF1 ADRB2 BRCA1 LMNA ACD CFL1 KIF14 ZFHX3 ANKRD36 HSPA6	3.17e-05	686	60	10	int:GAPDH
Interaction	SERPINH1 interactions	ADRB2 BRCA1 BRCA2 CFL1 CEP70 KIF14 ROS1	3.37e-05	306	60	7	int:SERPINH1
Interaction	NPM1 interactions	RC3H2 SETD2 PBRM1 BRCA1 LMNA BRCA2 MYO5A CFL1 ZBTB21 SYCP1 KIF14 NEB ESF1	4.19e-05	1201	60	13	int:NPM1
Interaction	SLX4 interactions	BRCA1 LMNA BRCA2 BAZ2B CFL1 ZNF451 ZBTB21 HSPA6 ESF1	4.57e-05	572	60	9	int:SLX4
Interaction	CDK16 interactions	RC3H2 BRCA1 LMNA ZBTB21 KIF14	4.57e-05	132	60	5	int:CDK16
Interaction	CALM3 interactions	RC3H2 ADRB2 CFL1 ROS1 MYO5C EPHA4 ITPR2	6.93e-05	343	60	7	int:CALM3
Interaction	TCEANC interactions	BRCA1 LMNA TNIP3 CEP70 OBI1	7.15e-05	145	60	5	int:TCEANC
Interaction	POT1 interactions	RIF1 BRCA1 ACD CFL1 ZNF790 MYO5C	7.31e-05	237	60	6	int:POT1
Interaction	FAM118B interactions	LMNA CEP70 CEP126 EPHA4	8.59e-05	78	60	4	int:FAM118B
Interaction	ZNF790 interactions	ACD ZNF790	8.67e-05	5	60	2	int:ZNF790
Interaction	TMOD4 interactions	MYO5A NEB MYO5C	8.68e-05	29	60	3	int:TMOD4
Interaction	SLU7 interactions	RC3H2 SETD2 LMNA CEP70 KIF14	1.01e-04	156	60	5	int:SLU7
Interaction	ODF2 interactions	BRCA1 CFL1 KIF14 CEP128 MAP3K1	1.07e-04	158	60	5	int:ODF2
Interaction	CBX3 interactions	RIF1 SETD2 BRCA1 LMNA ZNF451 ZNF184 ZBTB21 KIF14 ESF1	1.16e-04	646	60	9	int:CBX3
Interaction	POLN interactions	BRCA1 BRCA2 ELP4	1.17e-04	32	60	3	int:POLN
Interaction	CFAP184 interactions	SETD2 BRCA2 CEP95 EXOC1 ICE1	1.21e-04	162	60	5	int:CFAP184
Interaction	EEA1 interactions	USP8 ADRB2 LMNA KIF14 EEA1	1.21e-04	162	60	5	int:EEA1
Interaction	ZNF25 interactions	ADRB2 LMNA	1.30e-04	6	60	2	int:ZNF25
Interaction	CLIC1 interactions	BRCA1 LMNA ZNF184 KIF14 MYO5C	1.31e-04	165	60	5	int:CLIC1
Interaction	KRT38 interactions	LMNA BRCA2 EEA1 KRT79 MYO5C	1.60e-04	172	60	5	int:KRT38
Interaction	BRIP1 interactions	PBRM1 BRCA1 LMNA BRCA2	1.63e-04	92	60	4	int:BRIP1
Interaction	PIAS4 interactions	RIF1 BRCA1 LMNA BRCA2 ZNF445	1.64e-04	173	60	5	int:PIAS4
Interaction	ZNF594 interactions	ANKRD36B ZNF594	1.81e-04	7	60	2	int:ZNF594
Interaction	CXCL6 interactions	SETD2 MYO5A MYO5C	1.81e-04	37	60	3	int:CXCL6
Interaction	SFR1 interactions	PBRM1 CEP70 EXOC1	1.81e-04	37	60	3	int:SFR1
Interaction	CDC5L interactions	RC3H2 RIF1 BRCA1 LMNA ZNF451 KIF14 EXOC1 PSTPIP2 HSPA6 GOLGB1	1.97e-04	855	60	10	int:CDC5L
Interaction	CWF19L2 interactions	BRCA1 LMNA BRCA2 CEP70 KIF14	2.08e-04	182	60	5	int:CWF19L2
Interaction	TULP2 interactions	PBRM1 BRCA1 MYO5C	2.12e-04	39	60	3	int:TULP2
Interaction	ZBTB14 interactions	BRCA1 BRCA2 BAZ2B ZBTB21	2.25e-04	100	60	4	int:ZBTB14
Interaction	KRT37 interactions	LMNA ANKRD36 EEA1 KRT79	2.25e-04	100	60	4	int:KRT37
Interaction	SHANK1 interactions	USP8 BRCA2 KIF14	2.47e-04	41	60	3	int:SHANK1
Interaction	AP2A1 interactions	RC3H2 ADRB2 BRCA1 KIF14 CEP128 MYO5C	2.59e-04	299	60	6	int:AP2A1
Interaction	GOLGA2 interactions	ZNF594 BAZ2B CEP95 ZBTB21 KIF14 ZFHX3 ICE1 ANKRD36 GOLGB1	2.98e-04	733	60	9	int:GOLGA2
Interaction	PHIP interactions	PBRM1 LMNA ZFHX4 KIF14 ZFHX3	3.00e-04	197	60	5	int:PHIP
Interaction	DCAF12 interactions	SETD2 BRCA2 BAZ2B ZFHX3	3.02e-04	108	60	4	int:DCAF12
Interaction	SMTN interactions	BRCA1 LMNA KIF14	3.05e-04	44	60	3	int:SMTN
Interaction	PIBF1 interactions	TNIP3 CEP70 ZFHX3 EEA1 CEP128	3.21e-04	200	60	5	int:PIBF1
Interaction	ORC2 interactions	BRCA1 LMNA KIF14 OBI1	3.24e-04	110	60	4	int:ORC2
Interaction	NDC80 interactions	CEP95 KIF14 EXOC1 ICE1 CEP128 MYO5C	3.25e-04	312	60	6	int:NDC80
Interaction	H2AX interactions	PBRM1 BRCA1 LMNA BRCA2 CFL1 KIF14 PHF14 NEB	3.56e-04	593	60	8	int:H2AX
Interaction	CTTN interactions	LMNA ACD BRCA2 MYO5A CFL1 KIF14 MYO5C	3.67e-04	450	60	7	int:CTTN
Interaction	HDAC1 interactions	BRCA1 ZFHX4 BRCA2 ZBTB21 KIF14 PHF14 ZFHX3 CEP128 OBI1 HSPA6 GOLGB1	3.77e-04	1108	60	11	int:HDAC1
Interaction	XRCC6 interactions	RC3H2 RIF1 BRCA1 LMNA ACD BRCA2 KIF14 ZFHX3 ICE1 ESF1	3.79e-04	928	60	10	int:XRCC6
Interaction	HDAC6 interactions	PBRM1 ADRB2 LMNA BRCA2 MYO5A CFL1 CEP70 KIF14 HSPA6 GOLGB1	3.82e-04	929	60	10	int:HDAC6
Interaction	AURKB interactions	RC3H2 RIF1 SETD2 ABR LMNA BRCA2 KIF14 ZNF782 OBI1	3.92e-04	761	60	9	int:AURKB
Interaction	YWHAQ interactions	USP8 ADRB2 BRCA1 LMNA CEP95 CFL1 ZBTB21 KIF14 NEB GOLGB1 MAP3K1	4.07e-04	1118	60	11	int:YWHAQ
Interaction	YWHAZ interactions	PDC USP8 BRCA1 LMNA MYO5A CEP95 CFL1 ZBTB21 KIF14 CEP126 NEB MAP3K1	4.37e-04	1319	60	12	int:YWHAZ
Interaction	ZNF239 interactions	LMNA CEP70	4.71e-04	11	60	2	int:ZNF239
Interaction	HSP90AB1 interactions	USP8 RC3H2 BRCA1 ACD BRCA2 BAZ2B KIF14 ROS1 NEB HSPA6	4.95e-04	960	60	10	int:HSP90AB1
Cytoband	15q21	MYO5A MYO5C	9.17e-05	11	60	2	15q21
Cytoband	Ensembl 112 genes in cytogenetic band chr3p21	CACNA1D SETD2 PBRM1 ZNF445	7.93e-04	316	60	4	chr3p21
Cytoband	Ensembl 112 genes in cytogenetic band chr2q11	ANKRD36B ANKRD36 ANKRD36C	1.08e-03	153	60	3	chr2q11
Cytoband	Ensembl 112 genes in cytogenetic band chr15q21	USP8 MYO5A MYO5C	1.64e-03	177	60	3	chr15q21
Cytoband	Ensembl 112 genes in cytogenetic band chr2q23	RIF1 NEB	2.22e-03	53	60	2	chr2q23
Cytoband	11p13	RAG1 ELP4	2.47e-03	56	60	2	11p13
Cytoband	2q11.2	ANKRD36B ANKRD36	4.05e-03	72	60	2	2q11.2
Cytoband	Ensembl 112 genes in cytogenetic band chr5q32	PDE6A ADRB2	4.97e-03	80	60	2	chr5q32
GeneFamily	Myosins, class V	MYO5A MYO5C	1.73e-05	3	44	2	1100
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF594 ZNF451 ZNF184 ZNF790 ZBTB21 ZFHX3 ZNF782 ZNF445	2.97e-04	718	44	8	28
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZFHX4 ZFHX3	5.96e-04	15	44	2	529
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA1 BRCA2	1.07e-03	20	44	2	548
GeneFamily	Zinc fingers CCCH-type	RC3H2 ZC3H6	3.27e-03	35	44	2	73
GeneFamily	Ring finger proteins	RAG1 RC3H2 BRCA1 OBI1	4.41e-03	275	44	4	58
GeneFamily	PHD finger proteins	BAZ2B PHF14	2.02e-02	90	44	2	88
GeneFamily	Ankyrin repeat domain containing	ANKRD36B ANKRD36 ANKRD36C	2.10e-02	242	44	3	403
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	PI4K2B USP8 RIF1 PBRM1 BRCA1 MYO5A BAZ2B CEP70 KIF14 EXOC1 EEA1 OBI1 GOLGB1 ESF1 ITPR2	1.52e-11	656	60	15	M18979
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RIF1 SETD2 BRCA1 BRCA2 BAZ2B ZNF451 KIF14 PHF14 ZFHX3 EPHA4	2.25e-05	856	60	10	M4500
Coexpression	E2F3_UP.V1_DN	RIF1 BRCA2 ZNF782 HSPA6 ESF1	3.62e-05	163	60	5	M2704
Coexpression	HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL	ANKRD36B RIF1 PBRM1 BRCA1 ACD BRCA2 KIF14 ANKRD36 ANKRD36C MAP3K1	4.92e-05	939	60	10	M45768
Coexpression	GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN	BRCA1 BRCA2 MYO5A KIF14 EEA1	5.51e-05	178	60	5	M2952
Coexpression	GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP	BRCA1 BRCA2 MYO5A KIF14 NEB	6.28e-05	183	60	5	M2993
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	RIF1 ADRB2 BAZ2B ZNF451 KIF14 ICE1	6.37e-05	300	60	6	M8702
Coexpression	GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP	BAZ2B ZNF451 EXOC1 ANKRD36 GOLGB1	9.56e-05	200	60	5	M9889
Coexpression	GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP	PDE6A ADRB2 MYO5A EEA1 MAP3K1	9.56e-05	200	60	5	M8532
Coexpression	LEE_EARLY_T_LYMPHOCYTE_UP	RAG1 CEP70 KIF14 CEP128	1.24e-04	111	60	4	M7357
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	RIF1 BRCA1 BRCA2 MYO5A ZNF184 CEP70 PHF14 ESF1	1.71e-06	311	57	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	RIF1 ADRB2 BRCA1 BRCA2 MYO5A ZNF184 CEP70 KIF14 PHF14 CEP126 CEP128 OBI1 ESF1 MYO5C	1.62e-05	1414	57	14	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	RIF1 BRCA1 BRCA2 MYO5A ZNF184 CEP70 KIF14 PHF14 CEP126 CEP128 OBI1 ESF1	1.98e-05	1060	57	12	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#1_top-relative-expression-ranked_500	RC3H2 RIF1 BAZ2B CFL1 ESF1	3.69e-05	140	57	5	gudmap_developingGonad_e18.5_testes_500_k1
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	RC3H2 RIF1 MYO5A SYCP1 EEA1 NEB KRT79 ESF1 ITPR2 ZNF445	3.73e-05	778	57	10	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#4_top-relative-expression-ranked_500	RC3H2 RIF1 BRCA1 BAZ2B CFL1 ESF1	4.49e-05	241	57	6	gudmap_developingGonad_e12.5_testes_k4_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	RIF1 MYO5A ZNF451 ZFHX3 ICE1 ZC3H6 ELP4 EPHA4	4.79e-05	492	57	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	RC3H2 RIF1 PBRM1 ZFHX4 CCDC30 ZNF451 ZFHX3 MAP3K1 ESF1 ZNF445	4.92e-05	804	57	10	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	RIF1 BRCA1 BRCA2 CEP95 ZNF451 SYCP1 CEP70 KIF14 ZC3H6 ESF1	5.24e-05	810	57	10	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	PI4K2B ABR BRCA1 ZFHX4 BRCA2 RAVER2 ZNF184 ZNF790 CEP70 PHF14 ZFHX3	5.25e-05	985	57	11	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000	RIF1 ZFHX4 MYO5A ZNF451 ZFHX3 ICE1 NEB ZC3H6 ELP4 EPHA4	6.83e-05	836	57	10	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_500	RC3H2 RIF1 BAZ2B CFL1 ESF1	8.53e-05	167	57	5	gudmap_developingGonad_e16.5_testes_500_k1
CoexpressionAtlas	DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#4_top-relative-expression-ranked_1000	RIF1 MYO5A SYCP1 EEA1 ITPR2	8.77e-05	168	57	5	gudmap_developingGonad_P2_ovary_1000_k4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	RIF1 BRCA1 BRCA2 MYO5A ZNF184 CEP70 PHF14 ZFHX3 CEP126 CEP128 OBI1 ESF1	1.04e-04	1257	57	12	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_500	RC3H2 RIF1 BAZ2B CFL1 ESF1	1.34e-04	184	57	5	gudmap_developingGonad_e14.5_ testes_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500	RIF1 ZFHX4 ZNF451 ZFHX3 NEB ZC3H6 EPHA4	1.45e-04	429	57	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500	RC3H2 RIF1 ZFHX4 BAZ2B CFL1 OBI1 ESF1	1.58e-04	435	57	7	gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000	RIF1 BRCA1 ZNF451 CEP70 KIF14 ESF1	2.63e-04	333	57	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000	RIF1 ZFHX4 MYO5A ZNF451 ZFHX3 ELP4 EPHA4	2.80e-04	478	57	7	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000	RC3H2 RIF1 PBRM1 ZFHX4 ZNF451 ZFHX3 OBI1 ESF1 ZNF445	2.98e-04	815	57	9	gudmap_developingGonad_e11.5_ovary + mesonephros_1000
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#2_top-relative-expression-ranked_1000	RC3H2 RIF1 BRCA1 BAZ2B CFL1 ESF1	3.38e-04	349	57	6	gudmap_developingGonad_P2_testes_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	RIF1 SETD2 BRCA1 BRCA2 MYO5A ZNF184 PHF14 EEA1 ESF1	3.43e-04	831	57	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#3_top-relative-expression-ranked_200	RIF1 CFL1 ESF1	3.69e-04	52	57	3	gudmap_developingGonad_e14.5_ testes_200_k3
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	RC3H2 RIF1 BRCA1 ZFHX4 BAZ2B CFL1 ZFHX3 OBI1 ESF1	3.81e-04	843	57	9	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_200	ZFHX4 ZFHX3 EPHA4	4.13e-04	54	57	3	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200_k2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	RIF1 BRCA1 BRCA2 MYO5A ZNF184 CEP70 PHF14 ZFHX3 CEP126 CEP128 OBI1 ESF1	4.14e-04	1459	57	12	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	DevelopingGonad_P2_testes_emap-30171_k-means-cluster#3_top-relative-expression-ranked_500	RIF1 BAZ2B CFL1 ESF1	4.89e-04	136	57	4	gudmap_developingGonad_P2_testes_500_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500	RIF1 ZFHX4 ZNF451 ZFHX3 EPHA4	5.23e-04	247	57	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500	RIF1 ZFHX4 ZFHX3 ELP4 EPHA4	5.43e-04	249	57	5	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500	RIF1 BRCA1 BRCA2 SYCP1 KIF14 ZC3H6	5.68e-04	385	57	6	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_500	RIF1 BRCA1 BRCA2 ZNF451 SYCP1 KIF14	5.84e-04	387	57	6	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_500
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500	RIF1 BRCA2 ZNF451 SYCP1 CEP70 KIF14	6.59e-04	396	57	6	gudmap_dev gonad_e13.5_M_GermCell_Oct_500
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500	RIF1 BRCA1 BRCA2 ZNF451 SYCP1 KIF14	7.50e-04	406	57	6	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_500	RC3H2 RIF1 BRCA1 BAZ2B CFL1 ESF1	7.50e-04	406	57	6	gudmap_developingGonad_e12.5_testes_500
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500	RC3H2 RIF1 BAZ2B CFL1 SYCP1 ESF1	7.99e-04	411	57	6	gudmap_developingGonad_e14.5_ testes_500
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500	RIF1 PBRM1 ZFHX4 ZFHX3 ESF1 ZNF445	8.62e-04	417	57	6	gudmap_developingGonad_e11.5_ovary + mesonephros_500
CoexpressionAtlas	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4	RC3H2 BRCA1 BRCA2 MYO5A CEP95 ZNF184 KIF14 PHF14 CEP126 OBI1 ESF1	9.13e-04	1370	57	11	facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#5_top-relative-expression-ranked_1000	RC3H2 RIF1 BRCA1 BAZ2B CFL1 ESF1	9.98e-04	429	57	6	gudmap_developingGonad_e14.5_ testes_1000_k5
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	CACNA1D SETD2 PHF14 ITPR2	1.03e-03	166	57	4	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3	RIF1 ZFHX4 BRCA2 CEP70 GOLGB1 ESF1	1.03e-03	432	57	6	Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	SETD2 BRCA1 BRCA2 CEP95 ZNF184 CEP70 PHF14 EEA1	1.07e-03	780	57	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BRCA1 BRCA2 ZNF184 CEP70 PHF14	1.09e-03	291	57	5	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_500	RC3H2 RIF1 ZFHX4 CFL1 OBI1 ESF1	1.10e-03	437	57	6	gudmap_developingGonad_e11.5_testes_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	RIF1 SETD2 BRCA1 BRCA2 MYO5A ZNF184 CEP70 PHF14 ESF1	1.19e-03	989	57	9	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	BRCA2 CEP70 PHF14 CEP126 GOLGB1	1.21e-03	298	57	5	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	RC3H2 RIF1 MYO5A SYCP1 MAP3K1 ESF1 ITPR2 ZNF445	1.21e-03	795	57	8	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000	RIF1 BRCA1 BRCA2 ZNF451 SYCP1 CEP70 KIF14 ESF1	1.21e-03	795	57	8	gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	RC3H2 RIF1 BAZ2B ZNF451 ZFHX3 MAP3K1 ESF1 ZNF445	1.27e-03	801	57	8	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	RC3H2 RIF1 PBRM1 BRCA1 ZNF451 MAP3K1 ESF1 ZNF445	1.33e-03	806	57	8	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_200	RC3H2 ZFHX4 CFL1 ESF1	1.36e-03	179	57	4	gudmap_developingGonad_e11.5_testes and mesonephros_200
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	RIF1 BRCA1 BRCA2 ZNF451 SYCP1 KIF14 ZC3H6 ESF1	1.48e-03	820	57	8	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	RIF1 BRCA1 BRCA2 ZNF184 CEP70 PHF14 ZFHX3 CEP126 ESF1 ITPR2	1.57e-03	1241	57	10	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BRCA2 ZNF184 CEP70 PHF14	1.57e-03	186	57	4	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	RIF1 BRCA2 ZNF184 CEP70 PHF14 ZFHX3 CEP126 CEP128 ESF1 EPHA4	1.67e-03	1252	57	10	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#5_top-relative-expression-ranked_200	RIF1 CFL1 ESF1	1.71e-03	88	57	3	gudmap_developingGonad_e12.5_testes_k5_200
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000	BRCA1 CEP126 OBI1 EPHA4	1.73e-03	191	57	4	gudmap_kidney_P2_CapMes_Crym_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_200	ZFHX4 EPHA4	1.73e-03	23	57	2	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_200
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	RIF1 BRCA1 BRCA2 ESF1	1.76e-03	192	57	4	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	RC3H2 RIF1 BRCA1 ZFHX4 BAZ2B CFL1 OBI1 ESF1	1.77e-03	844	57	8	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000	RIF1 ZFHX4 MYO5A ZNF451 ZFHX3 NEB ELP4 EPHA4	1.85e-03	850	57	8	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_200	ZFHX4 ZFHX3 EPHA4	1.88e-03	91	57	3	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_200_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	PI4K2B BRCA1 ZFHX4 BRCA2 CEP70 ZFHX3	2.00e-03	492	57	6	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
ToppCell	moderate-Epithelial-FOXN4+\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BRCA2 ZBTB21 ANKRD36 CEP126 ANKRD36C MYO5C	2.45e-07	194	60	6	5dffa578149104dda33774361e9e77b227b5f1ce
ToppCell	moderate-Epithelial-FOXN4+\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BRCA1 BRCA2 CEP95 ZBTB21 ANKRD36 CEP128	2.45e-07	194	60	6	dff3fb10372053951d41e0ccd41aac3ece6009bd
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	LMNA PHF14 ANKRD36 ANKRD36C GOLGB1 ESF1	2.69e-07	197	60	6	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	2.98e-06	166	60	5	739dfbe927f409821ff23aca6e47ebe78f57e859
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD36B CEP95 ANKRD36 GOLGB1 MAP3K1	3.07e-06	167	60	5	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	3.35e-06	170	60	5	84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	3.55e-06	172	60	5	adc09c4d1b63fe84150516beb692db1e7f7ac980
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	3.55e-06	172	60	5	cecfe5cf20f317ea01b4604789e07a14481c4cd6
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B BAZ2B ANKRD36C GOLGB1 MYO5C	4.31e-06	179	60	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	ZFHX4 MYO5A SCN7A EEA1 ITPR2	4.93e-06	184	60	5	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	Brain_organoid-organoid_Kanton_Nature\|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type.	ANKRD36B BAZ2B PHF14 ICE1 ANKRD36C	5.06e-06	185	60	5	857c7ca8493e91ef1d0078ddafd6082020f9b169
ToppCell	Control-Endothelial-Endothelial-FOXM1\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA1 BRCA2 SYCP1 KIF14 CEP128	5.62e-06	189	60	5	1e1499b062d9c647c8f38b0c4e0d871d159be5dd
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B TNIP3 ANKRD36 ANKRD36C GOLGB1	6.54e-06	195	60	5	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	ANKRD36B SETD2 PHF14 ANKRD36 ANKRD36C	6.54e-06	195	60	5	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	ANKRD36B ANKRD36 CEP126 EEA1 GOLGB1	7.22e-06	199	60	5	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	7.39e-06	200	60	5	501cd2b4e55444fc5fdd93ebbcfc0616442b110b
ToppCell	Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative\|URO / Disease, condition lineage and cell class	BRCA1 BRCA2 KIF14 ANKRD36C CEP128	7.39e-06	200	60	5	f277db6cc288a52a5426120c1067608700ee8ccc
ToppCell	Control_saline-Endothelial-Endothelial-FOXM1\|Control_saline / Treatment groups by lineage, cell group, cell type	BRCA1 BRCA2 CEP70 KIF14 CEP128	7.39e-06	200	60	5	9bbc7b5561151f6ff65f40b3226271def732e5d9
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)---L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	7.39e-06	200	60	5	046a3a4d7e4d84ee4252a695ffd4a6aee8b77070
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	7.39e-06	200	60	5	893cc7f6b9794da90aa0c9d721b8647dc97201cd
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	7.39e-06	200	60	5	3d677f13e429abc805a52ec2b8f36c703f511569
ToppCell	Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_1(EFTUD1P1)--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	TTC29 TNIP3 ZFHX3 ROS1 ITPR2	7.39e-06	200	60	5	12518f4a8d01fc66b72878cdf0ba124b37cff3d8
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PDC SYCP1 KIF14	3.29e-05	46	60	3	771bca319a0324b551b1d83bd6eba1e033a12d26
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7\|TCGA-Brain / Sample_Type by Project: Shred V9	PI4K2B BRCA2 KIF14 MAP3K1	3.42e-05	136	60	4	d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	ANKRD36B ANKRD36 ANKRD36C KRT79	5.83e-05	156	60	4	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	6.13e-05	158	60	4	3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-CD1c-positive_myeloid_dendritic_cell-DC2_(CD1c+_dendritic_cell)-DC2_L.1.2.1.3\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 MYO5A ZNF782 HSPA6	7.25e-05	165	60	4	76abebe80e5f8bf44825bb619ae86fcb6f66ffeb
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TNIP3 ZFHX3 ROS1 ITPR2	7.25e-05	165	60	4	e381bcd558745f3a60346f78b49d0b2672184baa
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TNIP3 ZFHX3 ROS1 ITPR2	7.25e-05	165	60	4	fee7f2f8d0e25c0d067adc73f8913721bd709a3e
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	7.59e-05	167	60	4	a6ff7a3d9b80839c0efa91658836812e868561fa
ToppCell	3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZFHX3 PSTPIP2 EPHA4 ITPR2	7.95e-05	169	60	4	05e12524d68d409fed386ffad233305683b4575b
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	7.95e-05	169	60	4	ccb7b2daa65cb5f4c1e7a48b3bcdf0cb8f7675c3
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	7.95e-05	169	60	4	0bc8ef341ce307b19018d4ac8de0a4d04254209d
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	7.95e-05	169	60	4	2abdd8ae9a5d88aac30992142d1b502c959bc015
ToppCell	PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ABR CEP70 KIF14 PSTPIP2	8.13e-05	170	60	4	7534ac69ca3a378df78d61c284e89bc96a71a4a8
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	LMNA ANKRD36 ANKRD36C GOLGB1	8.32e-05	171	60	4	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	8.70e-05	173	60	4	37457ce2b0bb2a56d6e56f6fd9c668eb40c70ae0
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	8.90e-05	174	60	4	84da9faff088d05233183b425385beb054c92d1b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	8.90e-05	174	60	4	dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TTC29 TNIP3 ZFHX3 ROS1	9.30e-05	176	60	4	ed421d8525108d2f585265d2cf777f07b29f44f0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	9.93e-05	179	60	4	80112c686a8f85ad5e3cda6e3f3d3d51cf688092
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BRCA1 BRCA2 KIF14 CEP128	1.01e-04	180	60	4	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	1.01e-04	180	60	4	f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTC29 SCN7A KIF14 CEP128	1.04e-04	181	60	4	c26d3cbbc592299786d79d1b15fc6bead2aafb9a
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B ANKRD36 ANKRD36C GOLGB1	1.10e-04	184	60	4	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	1.13e-04	185	60	4	30e041d6f6e310d64809e9d6d93cd30052972f3b
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP8 PBRM1 ZNF184 MAP3K1	1.15e-04	186	60	4	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	1.17e-04	187	60	4	9351fa87b69a951af85b10bf91fe9b1cce8c0517
ToppCell	Monocytes-M2-like_CD16+_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	BRCA2 BAZ2B NEB ITPR2	1.17e-04	187	60	4	59e31c51183ed4c9a3d0792c8005ea3a12b28dfa
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 CEP128	1.17e-04	187	60	4	057569c9437219ecc396aa6e673b1178a2273837
ToppCell	droplet-Marrow-nan-3m-Hematologic-erythroblast\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PI4K2B BRCA1 LMNA BRCA2	1.22e-04	189	60	4	8a38baee58a27c2fa3f4bd131ab9f15723ed9295
ToppCell	NS-moderate-d_16-33-Epithelial-FOXN4+\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	BRCA1 BRCA2 ZBTB21 CEP128	1.25e-04	190	60	4	250ca4a605c1cccd77d23383e4fe6f91cf3609ba
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SETD2 ANKRD36C GOLGB1 MAP3K1	1.25e-04	190	60	4	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ZFHX4 ZFHX3 CEP126 EPHA4	1.25e-04	190	60	4	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 KIF14 ANKRD36C	1.25e-04	190	60	4	31de1727822e9818652946dfb962daee77ffad68
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 BRCA2 ANKRD36 ANKRD36C	1.25e-04	190	60	4	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 BRCA2 ANKRD36 ANKRD36C	1.25e-04	190	60	4	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B ANKRD36 ANKRD36C GOLGB1	1.25e-04	190	60	4	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRCA1 BRCA2 KIF14 CEP128	1.25e-04	190	60	4	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B ANKRD36 ANKRD36C GOLGB1	1.25e-04	190	60	4	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	COVID-19-kidney-Proliferating_T_cell\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BRCA2 KIF14 CEP128 HSPA6	1.27e-04	191	60	4	bae388e0e9447d576e68465d73d8313ef6925ffa
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_2\|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.	ZFHX4 CFL1 ZFHX3 EPHA4	1.27e-04	191	60	4	509d17d8ee0d028757ce0f2c9b97e5875f06f0ab
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD36B TNIP3 ANKRD36 ANKRD36C	1.33e-04	193	60	4	463274f394757fb2570ae885d58e1f9fa7e60c4a
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 BRCA2 TNIP3 KIF14	1.33e-04	193	60	4	444de545117dae8ab24a22880583ac2f0b2d6eac
ToppCell	human_hepatoblastoma-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	BRCA1 BRCA2 KIF14 CEP128	1.33e-04	193	60	4	4b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCell	Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5A PSTPIP2 HSPA6 ITPR2	1.35e-04	194	60	4	663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCell	wk_20-22-Hematologic_Lymphocytic-B-Pro-B\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	RAG1 BRCA1 BRCA2 KIF14	1.35e-04	194	60	4	3590ff471f74a361ee5bf02a58e3104cd3bf7d00
ToppCell	368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	PSTPIP2 HSPA6 ITPR2 ZNF445	1.35e-04	194	60	4	58046894446cb250814252a23f60fdd59c114d77
ToppCell	COVID-19-T_cells-Cycling_NK/T_cells\|COVID-19 / group, cell type (main and fine annotations)	BRCA1 BRCA2 KIF14 CEP128	1.38e-04	195	60	4	764ed100c28d9bc93ee5ecabc5291c8f184d78da
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.38e-04	195	60	4	926eb3fc5d028be936885bea0654a77db3107234
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.38e-04	195	60	4	1a5e814e12fe37287dbfc58189e1958e2c76b5da
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.41e-04	196	60	4	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.41e-04	196	60	4	1964c5003a0cb84539850a7cfe3bbb0e23a61d2d
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.41e-04	196	60	4	73f951f7712e0aa3323676b9a4b7944d21d347c4
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.44e-04	197	60	4	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BRCA1 BRCA2 KIF14 CEP128	1.44e-04	197	60	4	84ed777cdba569200a3ef1654d8a12f17fcfb7f1
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ABR PSTPIP2 HSPA6 ITPR2	1.44e-04	197	60	4	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	proximal-3-Hematologic-Proliferating_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 BRCA2 KIF14 KRT79	1.44e-04	197	60	4	0dd9058aa19d1268ebba9a65555870224b5a5978
ToppCell	proximal-Hematologic-Proliferating_Macrophage\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 BRCA2 KIF14 KRT79	1.44e-04	197	60	4	0b1fa881abbfcc54b322fc27124db3f8947af016
ToppCell	proximal-Hematologic-Proliferating_Macrophage-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 BRCA2 KIF14 KRT79	1.44e-04	197	60	4	9243617b307acf3df40d93c41cd8d4788699a7ea
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BRCA1 BRCA2 TNIP3 KIF14	1.46e-04	198	60	4	428182c71f009906c581e02257e545ea5fb99650
ToppCell	critical-Epithelial-FOXN4+\|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	BRCA2 ZBTB21 ANKRD36 MYO5C	1.46e-04	198	60	4	6b160b3d6a2c1b1641c2c7dcec1a7ef38411fec9
ToppCell	distal-Hematologic-Proliferating_Macrophage-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	BRCA1 BRCA2 TNIP3 KIF14	1.46e-04	198	60	4	8afeb1f9bc9d8551482c8fefe4c5f88d9cd13ee2
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	BAZ2B PHF14 ANKRD36 ANKRD36C	1.46e-04	198	60	4	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ZNF451 ANKRD36 ANKRD36C GOLGB1	1.49e-04	199	60	4	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	BAZ2B ANKRD36 EEA1 GOLGB1	1.49e-04	199	60	4	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ANKRD36B TNIP3 ANKRD36 ANKRD36C	1.49e-04	199	60	4	2ac716f887687b5109fb9feced75d5c62646a268
ToppCell	LPS_IL1RA-Endothelial-Endothelial-FOXM1\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BRCA1 BRCA2 CEP70 KIF14	1.49e-04	199	60	4	be2276c9a1994579ba1d2998b49bf549c1324d44
ToppCell	Nasal_Brush-Epithelial-Goblet_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	ANKRD36B TNIP3 ANKRD36 ANKRD36C	1.49e-04	199	60	4	aa6f1390283617c7f9aaf91d379024832ea24a9e
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2\|World / Primary Cells by Cluster	BRCA1 ZFHX4 BRCA2 BAZ2B	1.52e-04	200	60	4	4923d7a4f00853c4d76fc1cc0fa82d522a2302e7
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	BRCA1 BRCA2 CEP70 KIF14	1.52e-04	200	60	4	4cfe08878a6981bf7b3567f9e82192d8f060ddde
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	LMNA EEA1 NEB ITPR2	1.52e-04	200	60	4	5ba4ed490c64b3bb738e7729669f893fa73aa56f
ToppCell	Non-neuronal-Dividing-IPC\|World / Primary Cells by Cluster	BRCA1 ZFHX4 BRCA2 KIF14	1.52e-04	200	60	4	971533181daa1bfac1f1b8c507d2013f891f9078
ToppCell	Non-neuronal-Dividing-IPC-IPC-div2-5\|World / Primary Cells by Cluster	BRCA1 ZFHX4 BRCA2 BAZ2B	1.52e-04	200	60	4	dc1c1506823eaa105f1532c6b5d4efa14e788314
ToppCell	Bronchus_Control_(B.)-Epithelial-TX-Club\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	ANKRD36B ANKRD36 ANKRD36C MYO5C	1.52e-04	200	60	4	292c63693eb7f435335a8cfba07aa35b72139393
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BRCA1 BRCA2 KIF14 CEP128	1.52e-04	200	60	4	af3dc76b4507bf4edd265169f5dfbbb8a19eb394
ToppCell	COVID-19-Myeloid-MoAM2,_CCL18\|Myeloid / Condition, Lineage and Cell class	LMNA MYO5A ZFHX3 ITPR2	1.52e-04	200	60	4	a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate\|2m / Sample Type, Dataset, Time_group, and Cell type.	ABR MYO5A BAZ2B PHF14	1.52e-04	200	60	4	2a635694844ddabcd98462c5636a6f41a3f08a46
ToppCell	Sigmoid-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	ZNF594 BRCA1 BRCA2 KIF14	1.52e-04	200	60	4	4e489ecf472857357d45e9f6c7a812aa48b72ebf
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BRCA1 BRCA2 KIF14 ANKRD36C	1.52e-04	200	60	4	63cc57b9331459efbb73051d174d198a3568b938
Computational	Genes upregulated in subsets of cells of a given type within various tumors	RIF1 ANKRD36C GOLGB1	7.12e-04	50	38	3	GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4
Computational	Genes upregulated in subsets of cells of a given type within various tumors	BAZ2B GOLGB1 MAP3K1	7.12e-04	50	38	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC
Computational	Genes upregulated in subsets of cells of a given type within various tumors	RIF1 SETD2 GOLGB1	7.12e-04	50	38	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Porins / transporters.	ADRB2 SCN7A ROS1 EPHA4 ITPR2	8.23e-04	211	38	5	MODULE_63
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	3.80e-06	2	58	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	3.80e-06	2	58	2	C4749652
Disease	colorectal cancer (is_marker_for)	SETD2 PBRM1 BRCA1 BRCA2 ZFHX3	1.46e-05	157	58	5	DOID:9256 (is_marker_for)
Disease	Hereditary breast ovarian cancer syndrome	BRCA1 BRCA2	2.27e-05	4	58	2	cv:C0677776
Disease	Auriculo-Ventricular Dissociation	CACNA1D LMNA	2.27e-05	4	58	2	C0004331
Disease	Heart Block	CACNA1D LMNA	2.27e-05	4	58	2	C0018794
Disease	blood phosphate measurement	USP8 ABR CFL1 ZFHX3 GOLGB1	2.40e-05	174	58	5	EFO_0010972
Disease	Prostatic Neoplasms	RAG1 SETD2 ADRB2 ABR BRCA1 BRCA2 ZFHX3 MAP3K1	2.64e-05	616	58	8	C0033578
Disease	Malignant neoplasm of prostate	RAG1 SETD2 ADRB2 ABR BRCA1 BRCA2 ZFHX3 MAP3K1	2.64e-05	616	58	8	C0376358
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA1 BRCA2	3.78e-05	5	58	2	DOID:5683 (is_implicated_in)
Disease	Adult only	BRCA1 BRCA2	5.67e-05	6	58	2	C3842001
Disease	Neoplasm of uncertain or unknown behavior of breast	PBRM1 BRCA1 BRCA2	7.29e-05	41	58	3	C0496956
Disease	Breast adenocarcinoma	PBRM1 BRCA1 BRCA2	7.29e-05	41	58	3	C0858252
Disease	esophagus squamous cell carcinoma (is_implicated_in)	BRCA1 BRCA2 MAP3K1	9.64e-05	45	58	3	DOID:3748 (is_implicated_in)
Disease	Pancreatic carcinoma, familial	BRCA1 BRCA2	1.35e-04	9	58	2	C2931038
Disease	Malignant tumor of prostate	BRCA2 ZFHX3	1.35e-04	9	58	2	cv:C0376358
Disease	lung non-small cell carcinoma (is_implicated_in)	PBRM1 BRCA1 ZFHX3 MAP3K1	1.64e-04	139	58	4	DOID:3908 (is_implicated_in)
Disease	Fanconi anemia (is_implicated_in)	BRCA1 BRCA2	1.69e-04	10	58	2	DOID:13636 (is_implicated_in)
Disease	cognitive behavioural therapy	SCN7A ZFHX3 NEB	2.06e-04	58	58	3	EFO_0007820
Disease	Benign tumor of pancreas	BRCA1 BRCA2	2.92e-04	13	58	2	C0347284
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BRCA2	3.40e-04	14	58	2	C0677776
Disease	Pancreatic carcinoma	BRCA1 BRCA2	6.36e-04	19	58	2	C0235974
Disease	Breast Carcinoma	SETD2 PBRM1 BRCA1 BRCA2 CFL1 MAP3K1	6.48e-04	538	58	6	C0678222
Disease	blood aluminium measurement	BAZ2B EPHA4	7.05e-04	20	58	2	EFO_0007575
Disease	Adenocarcinoma of prostate	BRCA1 BRCA2	7.05e-04	20	58	2	C0007112
Disease	BREAST CANCER	BRCA1 BRCA2	7.78e-04	21	58	2	114480
Disease	Pancreatic Neoplasm	BRCA1 BRCA2 SYCP1	1.02e-03	100	58	3	C0030297
Disease	Neoplasm of the genitourinary tract	BRCA2 ZFHX3	1.02e-03	24	58	2	cv:C0042065
Disease	Malignant neoplasm of pancreas	BRCA1 BRCA2 SYCP1	1.08e-03	102	58	3	C0346647
Disease	Fanconi Anemia	BRCA1 BRCA2	1.11e-03	25	58	2	C0015625
Disease	breast cancer (implicated_via_orthology)	BRCA1 BRCA2	1.11e-03	25	58	2	DOID:1612 (implicated_via_orthology)
Disease	Malignant neoplasm of breast	RIF1 SETD2 PBRM1 BRCA1 BRCA2 CFL1 GOLGB1 MAP3K1	1.14e-03	1074	58	8	C0006142
Disease	Malignant tumor of breast	BRCA1 BRCA2	1.29e-03	27	58	2	cv:C0006142
Disease	Breast neoplasm	BRCA1 BRCA2	1.29e-03	27	58	2	cv:C1458155
Disease	Familial cancer of breast	BRCA1 BRCA2	1.29e-03	27	58	2	cv:C0346153
Disease	Miller Dieker syndrome	BRCA1 BRCA2	1.49e-03	29	58	2	C0265219
Disease	Neoplasm of uncertain or unknown behavior of ovary	BRCA1 BRCA2	1.49e-03	29	58	2	C0496920
Disease	Ovarian Carcinoma	BRCA1 BRCA2	1.59e-03	30	58	2	C0029925
Disease	Breast Cancer, Familial	BRCA1 BRCA2	1.59e-03	30	58	2	C0346153
Disease	prostate cancer (is_implicated_in)	BRCA1 BRCA2 ZFHX3	1.60e-03	117	58	3	DOID:10283 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
EKCYDKTKVNKDNNE	ABR	571	Q12979
SKLFEDDEHEKEQYC	AKAP2	191	Q9Y2D5
YHVEQEKENKLLCED	ADRB2	366	P07550
KYQCLKDQLEEREKH	CEP128	781	Q6ZU80
IKHELQANCYEEVKD	CFL1	131	P23528
TDHCEQKEDLKEKDN	BAZ2B	1441	Q9UIF8
VNELNHSKEKECQYE	ANKRD36	1781	A6QL64
HSKEKECQYEKEKAE	ANKRD36	1786	A6QL64
ELNHSKEKECQYEKE	ANKRD36B	1221	Q8N2N9
ENKHYEVAKKCVEDL	RC3H2	91	Q9HBD1
KECNEEVSLEKYNHH	RAG1	361	P15918
NCQEVHDLLKDYDLK	RAVER2	81	Q9HCJ3
KKNYEQKCRDKDEAE	PSTPIP2	141	Q9H939
EQEKFLTCDEYEKKQ	ITPR2	246	Q14571
ELNHSKEKKCQYEKE	ANKRD36C	1646	Q5JPF3
EVYNEKIHDLLVCKD	KIF14	496	Q15058
KLKNQEYETLDHLEC	PBRM1	436	Q86U86
QHEDQVEQYKKELEK	LMNA	251	P02545
KNKYEDEINKHTAAE	KRT79	231	Q5XKE5
YSKAKQEADEEKHLN	EPHA4	576	P54764
DEDSKKHFNYNKIVE	ESF1	716	Q9H501
EYELIHKEKEDENCL	PDC	76	P20941
QDIVKYHVKCDNEEI	PDE6A	451	P16499
HKEYEDEIDCLQKEV	OBI1	96	Q5W0B1
KLENEQEKLHVEYNK	PHF14	646	O94880
LVRYEKQKCEKEIDH	PI4K2B	311	Q8TCG2
SNCKHPEIKKQEYEE	BRCA1	1101	P38398
QEHCSQLESHLKEYK	EEA1	701	Q15075
DTHQEYARVKEECLK	ICE1	111	Q9Y2F5
KIFHEANADECEKSK	BRCA2	331	P51587
VKCQHYKKKRTEQEE	CEP70	156	Q8NHQ1
KEEEIKYFNCNKEEL	CEP126	501	Q9P2H0
QLENEKRKYDEHVKS	CCDC30	451	Q5VVM6
KEYEHNKRLQDFKDC	CEP95	631	Q96GE4
DNLYKKVDKHLCEEE	EXOC1	826	Q9NV70
KEEYEHQKRELEQIC	HSPA6	591	P17066
DKCKKEFDEDVYNHK	ELP4	136	Q96EB1
QEQGEKEYKNCELDK	CACNA1D	1156	Q01668
TYKDDVNHNQKCKEK	MAP3K1	1166	Q13233
KQECIKAENQSHDYK	RIF1	1591	Q5UIP0
DLDVQKKLYDCLEEH	ACD	141	Q96AP0
TDENIKRKDHIDYQK	ZNF451	61	Q9Y4E5
HKEKSDEEEQQYVIK	ZNF451	776	Q9Y4E5
DLITHQKKQCYKDED	ZFHX4	2281	Q86UP3
ELKQEHESKCEYKKL	ZBTB21	761	Q9ULJ3
QCKFDHDAELEKRKE	ZC3H6	291	P61129
TLANKEKEHYECEIK	TNIP3	146	Q96KP6
EKEHYECEIKRLNKA	TNIP3	151	Q96KP6
QHLEQEYKKEINDKE	SYCP1	251	Q15431
EKEPHADKDFCQEKQ	ROS1	2306	P08922
ECNENVKHKTKEYIK	SETD2	2531	Q9BYW2
LHEEEKFYKQDECRE	ZNF445	646	P59923
EKIHNERKSYECKEC	ZNF790	441	Q6PG37
KEKDDIDHYLEVNFK	TTC29	36	Q8NA56
HNINKTYECKECEKT	ZNF594	121	Q96JF6
KNYEEFVCHIDKDCQ	SCN7A	651	Q01118
QYSKEKAHERNVCDK	ZNF782	156	Q6ZMW2
KRYKEENNDHLDDFK	USP8	891	P40818
QKTHTQEKAYECKEC	ZNF184	521	Q99676
HQKKLCYKDEDEEGQ	ZFHX3	2346	Q15911
HKAQEIYEKNLDEKA	GOLGB1	701	Q14789
EVEEDKENKEYSEKC	GOLGB1	1036	Q14789
KKCIEEHADRYKQET	MYO5A	1006	Q9Y4I1
LESHFQSQKDCYEKE	MYO5C	1151	Q9NQX4
CNDVQSELKYKAEHV	NEB	4241	P20929